| Thymic function as a predictor of immune recovery in chronically HIV-infected patients initiating antiretroviral therapy R Rb-Silva, C Nobrega, C Azevedo, E Athayde, J Canto-Gomes, I Ferreira, ... Frontiers in immunology 10, 25, 2019 | 46 | 2019 |
| Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients C Serre-Miranda, C Nobrega, S Roque, J Canto-Gomes, CS Silva, ... International Journal of Infectious Diseases 104, 661-669, 2021 | 25 | 2021 |
| HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation H Yang, H Sun, S Brackenridge, X Zhuang, PAC Wing, M Quastel, ... Science Immunology 8 (84), eabl8881, 2023 | 11 | 2023 |
| High dimensional immune profiling reveals different response patterns in active and latent tuberculosis following stimulation with mycobacterial glycolipids CS Silva, C Sundling, E Folkesson, G Fröberg, C Nobrega, ... Frontiers in Immunology 12, 727300, 2021 | 11 | 2021 |
| People with Primary Progressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells and HLA-DR+ Tregs J Canto-Gomes, S Da Silva-Ferreira, CS Silva, D Boleixa, ... Cells 12 (3), 439, 2023 | 6 | 2023 |
| Low memory T cells blood counts and high naïve regulatory T cells percentage at relapsing remitting multiple sclerosis diagnosis J Canto-Gomes, CS Silva, R Rb-Silva, D Boleixa, AM da Silva, ... Frontiers in Immunology 13, 901165, 2022 | 6 | 2022 |
| Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis J Canto-Gomes, D Boleixa, C Teixeira, AM da Silva, I Gonzalez-Suarez, ... International Immunopharmacology 131, 111826, 2024 | 1 | 2024 |
| Stimulation with mycobacterial glycolipids and PPD reveals different innate immune response profiles in active and latent TB CS Silva, C Sundling, E Folkeson, G Fröberg, C Nobrega, J Canto-Gomes, ... bioRxiv, 2021.04. 04.434373, 2021 | 1 | 2021 |
| Corrigendum to “Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis”[Int … J Canto-Gomes, D Boleixa, C Teixeira, AM da Silva, I González-Suárez, ... International Immunopharmacology 143, 113555, 2024 | | 2024 |
| Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patients (preprint) C Serre-Miranda, C Nobrega, S Roque, J Canto-Gomes, CS Silva, ... | | 2020 |
